Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Charles Serhan
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2005
View PDFchevron_right
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
Charles Serhan
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2005
View PDFchevron_right
Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory Responses
Charles Serhan
The American Journal of Pathology, 2001
View PDFchevron_right
Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production
Regino Perez-polo
The Journal of Immunology, 2008
View PDFchevron_right
Characterization of the Promoter and the Transcriptional Regulation of the Lipoxin A4 Receptor (FPR2/ALX) Gene in Human Monocytes and Macrophages
Martin Hersberger
The Journal of Immunology, 2012
View PDFchevron_right
Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors
Priyank Patel
Journal of Experimental Medicine, 1997
View PDFchevron_right
Lack of activity of 15-epi-lipoxin A4 on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function
Anna Planaguma
Clinical and Experimental Immunology, 2013
View PDFchevron_right
Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature
Vincenzo BRANCALEONE
The Journal of Immunology, 2011
View PDFchevron_right
Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins
Charles Serhan
TheScientificWorldJournal, 2002
View PDFchevron_right
Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent
James Johndrow
Nature Medicine, 2006
View PDFchevron_right
Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation
Ulf Hedin
International journal of cardiology, 2015
View PDFchevron_right
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side
Charles Serhan
Archivum immunologiae et therapiae experimentalis, 2001
View PDFchevron_right
Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
Charles Serhan
Journal of Experimental Medicine, 2000
View PDFchevron_right
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4
Bernard Pirotte
Biochemical Pharmacology, 2013
View PDFchevron_right
Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation
János Filep
Journal of Leukocyte Biology, 2008
View PDFchevron_right
Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1 -initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine-Chemokine Axis
Charles Serhan
Journal of Experimental Medicine, 1999
View PDFchevron_right
Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis
Marc Pouliot
Journal of Experimental Medicine, 1999
View PDFchevron_right
Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4
Anna Planaguma
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002
View PDFchevron_right
A novel rat lipoxin A 4 receptor that is conserved in structure and function
Charles Serhan
British Journal of Pharmacology, 2003
View PDFchevron_right
Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation: Stimulation of Macrophage Phagocytosis of Apoptotic Neutrophils In Vivo
Nicos A Petasis
Journal of the American Society of Nephrology, 2002
View PDFchevron_right
Formation of Endogenous “Antiinflammatory” Lipid Mediators by Transcellular Biosynthesis
Charles Serhan
American Journal of Respiratory and Critical Care Medicine, 2000
View PDFchevron_right
A Stable Aspirin-Triggered Lipoxin A4 Analog Blocks Phosphorylation of Leukocyte-Specific Protein 1 in Human Neutrophils
T. Ohira, G. Bannenberg, Charles Serhan
The Journal of Immunology, 2004
View PDFchevron_right
Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: Development of a specific 15-epi-LXA4 ELISA
Nicos A Petasis
Prostaglandins & Other Lipid Mediators, 1999
View PDFchevron_right
Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils
Charles Serhan
The FASEB Journal, 2001
View PDFchevron_right
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
Stefano Marullo, Charles Serhan
Nature Medicine, 2002
View PDFchevron_right
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF- B and AP-1 activation, and IL-8 gene expression in human leukocytes
János Filep, Charles Serhan
Proceedings of the National Academy of Sciences, 2002
View PDFchevron_right
Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells
Christina Villela
American Journal of Physiology-cell Physiology, 2005
View PDFchevron_right